Opus Genetics Inc. (IRD)
NASDAQ: IRD
· Real-Time Price · USD
1.16
0.05 (4.50%)
At close: Aug 20, 2025, 3:59 PM
1.13
-2.59%
After-hours: Aug 20, 2025, 06:52 PM EDT
Opus Genetics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -58.27M | -58.62M | -57.53M | -27.19M | -14.11M | -11.3M | -9.99M | 28.75M | 18.66M | 18.69M | 17.89M | -22.37M | -22.07M | -24.27M | -56.69M | -69.06M | -66.08M | -60.55M |
Depreciation & Amortization | 37K | 23K | 10K | 3K | 4K | 5K | 6K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K |
Stock-Based Compensation | 3.38M | 3.29M | 3.36M | 3.28M | 3.08M | 3.69M | 3.51M | 3.22M | 3.14M | 2.17M | 1.81M | 1.86M | 1.85M | 1.86M | 1.91M | 1.95M | 2.09M | 1.94M |
Other Working Capital | 4.75M | 4.45M | 6.31M | 3.26M | -435K | 1.13M | 477K | -4.03M | -2.83M | -4.33M | -5.04M | 55K | 609K | 1.02M | -200K | 139K | -117K | -766K |
Other Non-Cash Items | 20M | 24.05M | 25.49M | -11K | 1.26M | 1.26M | 1.28M | 1.36M | 104K | 113K | 170K | 282K | -126K | 1.48M | 35.22M | 48.09M | 47.78M | 46.51M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 3.03M | 2.4M | 3.09M | 10.33M | -1.7M | 3.16M | 4.08M | -10.2M | -273K | -4.14M | -5.55M | 95K | 1.13M | 1.2M | 181K | 933K | 658K | 216K |
Operating Cash Flow | -31.83M | -28.85M | -25.58M | -13.59M | -11.46M | -3.18M | -1.11M | 23.13M | 21.64M | 16.84M | 14.31M | -20.12M | -19.21M | -19.73M | -19.37M | -18.08M | -15.55M | -11.88M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 1.21M | 1.21M | 1.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100K | -100K | -100K | -100K | 539K | 539K | 539K |
Investing Cash Flow | 1.21M | 1.21M | 1.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100K | -100K | -100K | -100K | 539K | 539K | 539K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -215K | -538K | n/a | n/a | 215K | 538K | 449K | 1.43M | 1.75M |
Common Stock Repurchased | 372K | -73K | -79K | -42K | -42K | -42K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 14.87M | 13.94M | -232K | -328K | -331K | -309K | -248K | -118K | -46K | -101K | -104K | -285K | -390K | -1.44M | -1.42M | -3.33M | -3.25M | -2.22M |
Financial Cash Flow | 21.64M | 22.27M | 4.19M | 7.87M | 12.89M | 11.36M | 8.98M | 5.36M | 1.32M | 2.9M | 3.79M | 11.83M | 12.1M | 28.48M | 27.61M | 39.07M | 38.4M | 20.68M |
Net Cash Flow | -8.98M | -5.37M | -20.18M | -5.72M | 1.43M | 8.17M | 7.87M | 28.5M | 22.95M | 19.74M | 18.1M | -8.39M | -7.21M | 8.65M | 8.13M | 21.53M | 23.38M | 9.34M |
Free Cash Flow | -31.83M | -28.85M | -25.58M | -13.59M | -11.46M | -3.18M | -1.11M | 23.13M | 21.64M | 16.84M | 14.31M | -20.12M | -19.21M | -19.73M | -19.37M | -18.08M | -15.55M | -11.88M |